Get started
PACIFIC BIOSCIENCES OF CALIFORNIA INCPACIFIC BIOSCIENCES OF CALIFORNIA INCPACIFIC BIOSCIENCES OF CALIFORNIA INC

PACIFIC BIOSCIENCES OF CALIFORNIA INC

No trades
See on Supercharts
Overview
Financials News Ideas Technicals Forecast

P09 chart

Upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats

Market capitalization
‪450.01 M‬EUR
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−1.06EUR
Net income (FY)
‪−277.91 M‬EUR
Revenue (FY)
‪181.67 M‬EUR
Shares float
‪264.29 M‬
Beta (1Y)
3.29

About Pacific Biosciences of California, Inc.

Sector
Health Technology
Industry
Medical Specialties
CEO
Christian O. Henry
Website
pacb.com
Headquarters
Menlo Park
Employees (FY)
796
Founded
2000
FIGI
BBG00188TWM5
Pacific Biosciences of California, Inc. engages in the development, manufacture, and marketing of advanced sequencing solutions for genetic analysis. It operates through the following geographical segments: America, Europe, Middle East, and Africa, and Asia Pacific. The company was founded by Stephen Turner and Joseph Vincent Bonventre on July 14, 2000 and is headquartered in Menlo Park, CA.

Financials

Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

Ideas

See all ideas 

News

Keep reading

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating

An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Stock brokers

Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of P09 is 1.69 EUR — it has decreased by 4.71% in the past 24 hours. Watch PACIFIC BIOSCIENCES OF CALIFORNIA INC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on GETTEX exchange PACIFIC BIOSCIENCES OF CALIFORNIA INC stocks are traded under the ticker P09.
P09 stock has fallen by 4.21% compared to the previous week, the month change is a 11.74% rise, over the last year PACIFIC BIOSCIENCES OF CALIFORNIA INC has showed a 85.27% decrease.
We've gathered analysts' opinions on PACIFIC BIOSCIENCES OF CALIFORNIA INC future price: according to them, P09 price has a max estimate of 7.41 EUR and a min estimate of 1.85 EUR. Watch P09 chart and read a more detailed PACIFIC BIOSCIENCES OF CALIFORNIA INC stock forecast: see what analysts think of PACIFIC BIOSCIENCES OF CALIFORNIA INC and suggest that you do with its stocks.
P09 reached its all-time high on Feb 15, 2021 with the price of 49.46 EUR, and its all-time low was 0.92 EUR and was reached on Nov 14, 2012. View more price dynamics on P09 chart.
See other stocks reaching their highest and lowest prices.
P09 stock is 7.87% volatile and has beta coefficient of 3.29. Track PACIFIC BIOSCIENCES OF CALIFORNIA INC stock price on the chart and check out the list of the most volatile stocks — is PACIFIC BIOSCIENCES OF CALIFORNIA INC there?
Today PACIFIC BIOSCIENCES OF CALIFORNIA INC has the market capitalization of ‪450.01 M‬, it has decreased by 6.10% over the last week.
Yes, you can track PACIFIC BIOSCIENCES OF CALIFORNIA INC financials in yearly and quarterly reports right on TradingView.
PACIFIC BIOSCIENCES OF CALIFORNIA INC is going to release the next earnings report on Jul 31, 2024. Keep track of upcoming events with our Earnings Calendar.
P09 earnings for the last quarter are −0.27 EUR per share, whereas the estimation was −0.26 EUR resulting in a −5.26% surprise. The estimated earnings for the next quarter are −0.21 EUR per share. See more details about PACIFIC BIOSCIENCES OF CALIFORNIA INC earnings.
PACIFIC BIOSCIENCES OF CALIFORNIA INC revenue for the last quarter amounts to ‪35.97 M‬ EUR despite the estimated figure of ‪40.26 M‬ EUR. In the next quarter revenue is expected to reach ‪38.60 M‬ EUR.
P09 net income for the last quarter is ‪−72.45 M‬ EUR, while the quarter before that showed ‪−74.31 M‬ EUR of net income which accounts for 2.50% change. Track more PACIFIC BIOSCIENCES OF CALIFORNIA INC financial stats to get the full picture.
No, P09 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Jun 3, 2024, the company has 796.00 employees. See our rating of the largest employees — is PACIFIC BIOSCIENCES OF CALIFORNIA INC on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. PACIFIC BIOSCIENCES OF CALIFORNIA INC EBITDA is ‪−252.65 M‬ EUR, and current EBITDA margin is −138.48%. See more stats in PACIFIC BIOSCIENCES OF CALIFORNIA INC financial statements.
Like other stocks, P09 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade PACIFIC BIOSCIENCES OF CALIFORNIA INC stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So PACIFIC BIOSCIENCES OF CALIFORNIA INC technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating PACIFIC BIOSCIENCES OF CALIFORNIA INC stock shows the sell signal. See more of PACIFIC BIOSCIENCES OF CALIFORNIA INC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.